We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine

- Relapse Remitting Multiple Sclerosis
- Completed

Study Title: Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine

Teva Identifier: GA 9015

ClinicalTrials.gov Identifier: NCT00203099

Study Status: Completed

Trial Condition(s): Relapse Remitting Multiple Sclerosis

Interventions: Drug: Glatiramer Acetate, N-Acetylcysteine

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

neurology icon for clinical trials

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years to 50 Years

Trial Duration: 12/01/2004 - 06/01/2008

Phase: Phase 2

Study Type

Interventional